Mariela White, MD
Family Medicine · Cuyahoga Falls, OHNPI 1447814876
Payments from drug & device makers
Across 465 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$671
- GSK$500
- AstraZeneca$488
- Novo Nordisk$472
- Astellas Pharma US Inc$446
- plus $4K from 31 others
What the payments were for
- Food & beverage$7,826100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $1,409 |
| Lilly USA, LLC | 52 | $671 |
| GSK | 30 | $500 |
| AstraZeneca | 29 | $488 |
| Novo Nordisk | 37 | $472 |
| Astellas Pharma US Inc | 29 | $446 |
| Pfizer | 28 | $405 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $321 |
| Bayer | 16 | $297 |
| Otsuka America Pharmaceutical, Inc. | 12 | $227 |
| Phathom Pharmaceuticals, Inc. | 12 | $222 |
| Exact Sciences | 11 | $219 |
| Axsome Therapeutics, Inc. | 9 | $211 |
| Sumitomo Pharma America, Inc. | 10 | $193 |
| Boehringer Ingelheim | 10 | $173 |
| Merck | 10 | $155 |
| Corcept Therapeutics | 8 | $144 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $139 |
| Abbott | 7 | $139 |
| Lundbeck LLC | 7 | $137 |
| Amgen(2 entities) | 6 | $120 |
| Xeris Pharmaceuticals, Inc. | 6 | $117 |
| Amarin Pharma, Inc. | 5 | $108 |
| Novartis | 4 | $73 |
| Johnson & Johnson | 3 | $63 |
| Inspire Medical Systems, Inc. | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Kowa Pharmaceuticals America, Inc. | 2 | $46 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 3 | $38 |
| Dexcom, Inc. | 2 | $34 |
| Radius Health, Inc. | 2 | $29 |
| Averitas Pharma Inc. | 1 | $28 |
| Corium, LLC | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| RGH Enterprises LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SHINGRIX$122
- NURTEC ODT$118
How this compares
$7,826 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 99 | $114,970 |
| JardianceEmpagliflozin | 63 | $90,610 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $70,533 |
| RybelsusSemaglutide | 22 | $36,958 |
| FarxigaDapagliflozin Propanediol | 29 | $33,085 |
| TrulicityDulaglutide | 21 | $31,465 |
| OzempicSemaglutide | 23 | $27,761 |
| XareltoRivaroxaban | 14 | $21,478 |
| VascepaIcosapent Ethyl | 36 | $16,010 |
| MyrbetriqMirabegron | 22 | $14,623 |
| NexlizetBempedoic Acid/Ezetimibe | 14 | $11,139 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $3,598 |
| Atorvastatin Calcium | 368 | $3,257 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 104 | $2,584 |
| Levothyroxine Sodium | 262 | $2,426 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $405 | $114,97099 claims |
| Boehringer IngelheimJardiance | $173 | $90,61063 claims |
| GSKTrelegy Ellipta | $500 | $70,53357 claims |
| Novo NordiskRybelsus, Ozempic | $472 | $64,71945 claims |
| AstraZenecaFarxiga | $488 | $33,08529 claims |
| Lilly USA, LLCTrulicity | $671 | $31,46521 claims |
| Johnson & JohnsonXarelto | $63 | $21,47814 claims |
| Astellas Pharma US IncMyrbetriq | $446 | $14,62322 claims |
| Esperion Therapeutics, Inc.Nexlizet | $39 | $11,13914 claims |
| AbbVieSynthroid | $1,409 | $1,91533 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Cuyahoga Falls
- Tricia BedrickCuyahoga Falls$259K
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.